EY
Elizabeth Yeu Lin sold $898K of TARS stock
Elizabeth Yeu Lin, Chief Medical Officer of Tarsus Pharmaceuticals, Inc. (TARS), sold 11,578 shares of TARS stock worth $898K, per an SEC Form 4 filed Sep 3, 2026.
The sale was pre-arranged (a 10b5-1 plan or an option exercise), not a fresh decision.
The trade happened on Sep 1, 2026, 2 days before it was made public.
TARS has moved +6.3% since the trade date, from $74.05 to $78.68 (Nov 16, 2026 close).
- Traded
- Sep 1, 2026
- Disclosed
- Sep 3, 2026
- Filing delay
- 2 days
- Price since
- +6.3%
- Role
- Chief Medical Officer
- Source
- SEC Form 4